Kidney Disease

Multidisciplinary teams at TRI are working on understanding and improving diagnosis and treatments of kidney conditions including chronic kidney disease and diabetic kidney disease.

Chronic kidney disease affects 11.5% of the Australian community and is one of the few diseases in which mortality rates are worsening over time. The condition directly, or indirectly, contributes to the deaths of 13.5% of Australians; more than deaths due to breast cancer, bowel cancer, prostate cancer, suicide and motor vehicle accidents combined.

The Centre for Kidney Disease Research (CKDR) is a University of Queensland centre based at the Translational Research Institute. CKDR researchers are working at the forefront of global trends in research to understand the cellular and molecular basis of kidney disease and to trial innovative new clinical treatments to improve the health and well-being of people with kidney disease.  The Centre is headed by Prof David Johnson and A/Prof Glenda Gobe.

Prof Johnson is a leading Nephrologist and clinical researcher, working with his team at the Princess Alexandra Hospital to investigate how to:

  • develop cheap and novel solutions to prevent progressive kidney scarring and failure
  • reduce the risk of heart disease and serious infections in dialysis patients
  • prevent diabetes after kidney transplantation
  • increase the lifespan of a kidney transplant; and
  • best provide dialysis to patients with end-stage kidney failure.

A/Prof Glenda Gobe leads a multi-disciplinary team of lab-based researchers that include cell and molecular biologists, clinician scientists, veterinarians and biological engineers.  Her team is investigating:

  • the molecular pathways of kidney disease, especially for acute kidney injury and chronic kidney disease, including biomarker discovery and oxidative stress damage and modulation
  • characterisation of control of apoptosis in kidney cancers, especially metastatic cancers that are resistant to current therapies; and
  • renal fibrosis, its molecular pathways, and development of gene therapies for its control, especially in kidney disease.

Diabetic Kidney Disease

Mater-UQ's Professor Josephine Forbes is also working with her team to investigate ways to prevent progression of diabetic kidney disease by targeting mitochondrial function. Read more

Related News

Key Researchers
Glenda Gobe
David Johnson
Josephine Forbes
International Clinical Trials Day: Q and A with TRI’s Steve Turner On International Clinical Trials Day on 20 May, we honour the incredibly hardworking professionals in the clinical trials...Read more
NO BENEFIT FROM DRUG USED TO REDUCE HEART DISEASE IN KIDNEY PATIENTS Following a large-scale clinical trial, researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular...Read more
Improved care for kidney disease patients at core of research program Clinician-researcher, Professor David Johnson, is championing patient-centred kidney disease research. His work over the past two...Read more
Diabetes drug could prevent kidney failure An affordable diabetes drug could save generations of Australian families who live with polycystic kidney disease from kidney failure. MRFF funding for...Read more
A new study by Australian and New Zealand researchers will inform international clinical treatment guidelines for chronic kidney disease, after the team found a drug used to slow the disease in up to...Read more
Kidney Health Week 2018 Kidney Health Week starts from March 5 to 11. It is to raise awareness of kidney disease and Kidney Health® Australia encourages everyone to learn more about the risk...Read more
* PAGE UNDER CONSTRUCTION IN OCTOBER 2016 Translational Research From A Dietitian's Perspective QUT Intern Carly Booth and Clinician Researcher Dr Ingrid Hickman chat about Ingrid's view of...Read more
* PAGE UNDER CONSTRUCTION IN OCTOBER 2016 A Day In The Life Of Dr Ingrid Hickman QUT Intern Carly Booth and Clinician Researcher Dr Ingrid Hickman take a look at Ingrid's busy schedule, giving an...Read more
Dietary Methodology In Clinical Research From Blue Zone Diets To The Mediterranean Diet QUT Intern Carly Booth and Clinician Researcher Dr Ingrid Hickman explore the ways dietary methodologies can be...Read more